首页> 外文学位 >A novel cardiac pacing paradigm for atrial fibrillation and heart failure patients.
【24h】

A novel cardiac pacing paradigm for atrial fibrillation and heart failure patients.

机译:一种适用于心房颤动和心力衰竭患者的新型心脏起搏范例。

获取原文
获取原文并翻译 | 示例

摘要

It has been estimated that 4.6 million persons have heart failure, and 400,000 to 700,000 new cases develop each year and the U.S. Hospital discharges for HF rose from 399,000 in 1979 to 1,099,000 in 2004 according to the National Hospital Discharge Survey. Atrial fibrillation is the most common sustained cardiac arrhythmia in the United States. Recent studies have demonstrated that ventricular rate control is a viable treatment strategy for patients in atrial fibrillation.;In a number of cases, despite the electrical resynchronization of the ventricles using biventricular pacing (cardiac resynchronization therapy), heart failure patients in sinus rhythm do not respond to cardiac resynchronization therapy as with other heart failure patients. These non-responders may respond to our pacing paradigm which is the combined use of cardiac resynchronization therapy which is commonly designated as CRT and coupled pacing (CP) which will be referred to as CRT+CP.;Using a custom "Y"-lead adapter, an unmodified dual chamber clinical pacemaker can be used to achieve almost any combination of an experimental stimulation paradigm. And by using the asynchronous mode of a dual chamber pacemaker, the ventricles can be paced at rates sufficient to produce heart failure (180 to 240 beats per minute) which had been successfully accomplished as part of the research protocol in our coupled pacing paradigm studies. These specially designed Y connectors facilitated our coupled pacing and biventricular pacing paradigm studies, i.e. allowed us to induce AF and apply CP under experimental conditions.;My research on this novel pacing paradigm (CRT+CP) has shown that it slowed the contractile rate by half (116+/-16 cycles per minute vs. 259+/-15 cycles per minute). And CRT+CP as compared with CRT at a similar contractile rate (CRT-vagal stimulation at 103+/-14 cycles per minute) also dramatically increased both the diastolic period (48+/-6% vs. 27+/-3%, p=0.02) and the left ventricular ejection fraction (51+/-10% vs. 25+/-4%, p0.001) as well.;This research has further demonstrated that the addition of a coupled paced beat significantly increased the left ventricular strain. The addition of coupled pacing to biventricular pacing also improved the left ventricular ejection (51+/-10%) to that of sinus rhythm despite the continual acute atrial fibrillation. CP may be combined with biventricular pacing (CRT+CP) to slow the ventricular rate of mechanical contractions and further improve contractility to a greater extent than what has been observed by CRT alone in patients with dyssynchronized heart failure and atrial fibrillation.
机译:据《国家医院出院调查》估计,每年有460万人患有心力衰竭,每年发展40万至700,000例新病例,美国HF出院率从1979年的399,000上升至2004年的1,099,000。心房颤动是美国最常见的持续性心律不齐。最近的研究表明,对于心房颤动患者,心室率控制是一种可行的治疗策略。在许多情况下,尽管使用双心室起搏使心室电同步(心脏再同步治疗),但窦律性心力衰竭患者却没有与其他心力衰竭患者一样,对心脏再同步治疗也有反应。这些无反应者可能会响应我们的起搏范例,这是心脏再同步治疗(通常称为CRT)和耦合起搏(CP)(将被称为CRT + CP)的组合使用。;使用定制的“ Y”导联适配器,未经修改的双腔临床起搏器可用于实现实验刺激范例的几乎任何组合。通过使用双腔起搏器的异步模式,可以以足以产生心力衰竭(每分钟180至240次心跳)的速率对心室起搏,这已作为我们耦合起搏范式研究中研究方案的一部分成功完成。这些经过特别设计的Y型连接器促进了我们起搏和双心室起搏范例的耦合研究,即允许我们在实验条件下诱发房颤并应用CP。我对这种新型起搏范例(CRT + CP)的研究表明,它通过一半(每分钟116 +/- 16个周期与每分钟259 +/- 15个周期)。与CRT相比,CRT + CP的收缩率相似(CRT迷走神经刺激以103 +/- 14个循环/分钟的速率)也显着延长了舒张期(48 +/- 6%对27 +/- 3%) ,p = 0.02)和左心室射血分数(51 +/- 10%vs. 25 +/- 4%,p <0.001)。;这项研究进一步证明,加上耦合的节律性搏动会明显增加左心室劳损。尽管持续的急性心房颤动,但双心室起搏加上偶合起搏也使左心室射血(51 +/- 10%)改善为窦性心律。 CP可以与双心室起搏(CRT + CP)结合使用,以减慢心室机械性收缩的速度,并进一步改善收缩性,其程度较不同步的心力衰竭和心房颤动的患者单用CRT更为明显。

著录项

  • 作者

    Yanulis, George Emanuel.;

  • 作者单位

    Cleveland State University.;

  • 授予单位 Cleveland State University.;
  • 学科 Engineering Biomedical.
  • 学位 D.Eng.
  • 年度 2008
  • 页码 108 p.
  • 总页数 108
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号